Skip to content
This GLP
Updated September 2026A four-rung supply ladder

Belle Health review

The product-page figure is a twelve-month supply rate. One month of semaglutide costs $199.

The verdict

Belle charges $199 for a one-month supply of compounded semaglutide. Compounded tirzepatide costs $249 for a one-month supply. Both product pages lead with lower figures than these. Those lower figures are the twelve-month rung and a starter bundle.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection
Dose pricing
Flat across doses
States
50
From
From $199/mo
Dose published
No
Prescription
Required
Compounded
Yes — not FDA-approved
Pharmacy
Named
LegitScript
Claimed by provider

Belle is a telehealth clinic selling compounded GLP-1 injections by supply length. It also sells NAD+, sermorelin, glutathione and MIC+B12 injections. A tirzepatide microdose is filed under longevity, not weight loss. Two skin creams are listed and marked coming soon.

  1. Who writes the prescription, and what do they see?

    A licensed U.S. provider reviews the written intake and writes the prescription. There is no scheduled video call at any point. Follow-up happens by message, usually within 24 hours of the screening. The chief medical officer is named: Dr. Patrick Taylor, MD. A physician assistant and two registered nurses are also named on the site.

    The intake is a written screening that takes about five minutes. Approved orders ship from a U.S. compounding pharmacy in three to five days. Weight-loss plans include weekly sessions with a named registered dietitian. Nurse support is included in every plan at no extra charge. Pausing, skipping and canceling all run from the patient portal. Shipped medication cannot be returned or refunded.

  2. What happens when the dose goes up?

    The provider follows a slow-titration protocol, starting low and raising gradually. Dose increases are included in the price at no extra cost. The FAQ states the price does not change as the dose rises. One exception is printed on the tirzepatide card. The $175 tirzepatide bundle applies to starter doses only. No milligram schedule is published for either molecule.

  3. What the price includes

    Each molecule is sold in four supply lengths, each with its own monthly rate. Semaglutide costs $199, $135, $119 and $109 a month. Those rates belong to the one-, two-, six- and twelve-month supplies. Tirzepatide costs $249 for one month, $199 for six and $189 for twelve. Its two-month rung is the $175 starter bundle for new patients. The one-month figure is the rate paid without committing to a longer supply. How the longer supplies are billed is not stated beside them.

  4. What it claims, and what it cites

    Both molecules are compounded, and compounded drugs are not FDA-approved. The FDA does not review them for safety, effectiveness or quality before dispensing. Belle states this in a notice on each product page. Each pricing card names the pharmacies that may fill that product. Semaglutide lists Boudreaux, VialsRx and ReviveRX as its pharmacies.

Where it holds up, and where it does not

  • Strength: Pharmacies named on each pricing card
  • Strength: Chief medical officer named on the site
  • Strength: Price stated not to rise with dose
  • Strength: Weekly dietitian sessions included
  • Strength: No membership or consultation fee
  • Limitation: Headline figure is the twelve-month rung
  • Limitation: Tirzepatide lead figure is starter-dose only
  • Limitation: No milligram schedule published
  • Limitation: Shipped medication cannot be refunded
  • Limitation: States served confirmed only at screening

What the evidence says about this kind of treatment

The assessment above is about Belle Health. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A buyer who will commit to a longer supply for a lower monthly rate.
Wrong for
A buyer comparing single-month prices straight off the headline card.

How Belle Health compares

SellerWho it suitsGo
FORMA reader who has priced the manufacturer already and wants a prescriber namedSee FORM
CieloBuyers who want the commitment behind a headline rate spelled out in the asterisk under itSee Cielo
Tuyo HealthBuyers weighing a compounded plan against brand Wegovy or Zepbound at the same clinicSee Tuyo Health
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: MondaeMultiMedRxMyStart HealthNäkyNativeMedNavio MD

Sponsored alternative

Bodybuilding Health+

A reader unwilling to prepay a year before seeing how the drug goes

Check Bodybuilding Health+ availability →

Frequently asked

What does one month of semaglutide cost?
$199 for a one-month supply of the injection. The $109 on the product page is the twelve-month rung.
Is the $175 tirzepatide price open to everyone?
No. It is a two-month starter bundle for new patients on starter doses only. The page gives the regular rate for that rung as $219.
Which pharmacies fill Belle prescriptions?
The pricing cards name them product by product. The FAQ names BPI Labs, VitalRx Pharmacy, The Pharmacy Hub and Olympia Pharmaceuticals.
Is Belle Health expensive compared with other GLP-1 telehealth sellers?
Belle Health publishes a starting figure of $199/mo. Across the 273 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $399 with a median of $179, which puts Belle Health above the median. The other 19 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Glenn TorresStandards editor · Reviewed and last verified September 2026

How this was assessed. The four questions above are answered from Belle Health’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.